Found: 19
Select item for more details and to access through your institution.
Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 271, doi. 10.1007/s00262-007-0355-7
- By:
- Publication type:
- Article
A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr).
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 5, p. 453, doi. 10.1007/s00262-004-0616-7
- By:
- Publication type:
- Article
Comparison of IGLV2‐14 light chain sequences of patients with AL amyloidosis or multiple myeloma.
- Published in:
- FEBS Journal, 2023, v. 290, n. 17, p. 4256, doi. 10.1111/febs.16805
- By:
- Publication type:
- Article
Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: Implications for tumor vaccines with melanoma-associated antigens.
- Published in:
- International Journal of Cancer, 1996, v. 66, n. 2, p. 162, doi. 10.1002/(SICI)1097-0215(19960410)66:2<162::AID-IJC4>3.0.CO;2-0
- By:
- Publication type:
- Article
Cellular immune response to human renal-cell carcinomas: Definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-Lymphocyte (CTL) clones.
- Published in:
- International Journal of Cancer, 1994, v. 59, n. 6, p. 837, doi. 10.1002/ijc.2910590621
- By:
- Publication type:
- Article
Induction of tumor-cell lysis by bi-specific antibody recognizing ganglioside GD2 and T-cell antigen CD3.
- Published in:
- International Journal of Cancer, 1993, v. 55, n. 3, p. 465, doi. 10.1002/ijc.2910550324
- By:
- Publication type:
- Article
Immunorecognition of different ganglioside epitopes on human normal and melanoma tissues.
- Published in:
- International Journal of Cancer, 1992, v. 51, n. 4, p. 568, doi. 10.1002/ijc.2910510411
- By:
- Publication type:
- Article
Ganglioside GD3 shedding by human malignant melanoma cells.
- Published in:
- International Journal of Cancer, 1989, v. 44, n. 1, p. 155, doi. 10.1002/ijc.2910440127
- By:
- Publication type:
- Article
A high-throughput RNAi screen for detection of immune-checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes.
- Published in:
- EMBO Molecular Medicine, 2015, v. 7, n. 4, p. 450, doi. 10.15252/emmm.201404414
- By:
- Publication type:
- Article
Visualization of antigen-specific human cytotoxic T lymphocytes labeled with superparamagnetic iron-oxide particles.
- Published in:
- 2008
- By:
- Publication type:
- journal article
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 5, p. 799, doi. 10.1007/s00262-019-02315-x
- By:
- Publication type:
- Article
Designer T cells by T cell receptor replacement.
- Published in:
- European Journal of Immunology, 2006, v. 36, n. 11, p. 3052, doi. 10.1002/eji.200636539
- By:
- Publication type:
- Article
Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection.
- Published in:
- European Journal of Immunology, 2001, v. 31, n. 7, p. 2071, doi. 10.1002/1521-4141(200107)31:7<2071::AID-IMMU2071>3.0.CO;2-D
- By:
- Publication type:
- Article
Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer.
- Published in:
- Nature Medicine, 2002, v. 8, n. 6, p. 631, doi. 10.1038/nm0602-631
- By:
- Publication type:
- Article
Targeting the epidermal growth factor receptor (HER) family by T cell receptor gene-modified T lymphocytes.
- Published in:
- Journal of Molecular Medicine, 2010, v. 88, n. 11, p. 1113, doi. 10.1007/s00109-010-0660-z
- By:
- Publication type:
- Article
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE‐3).
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 8, p. 1341, doi. 10.1002/ijc.33881
- By:
- Publication type:
- Article
NY-ESO-1 antigen-reactive T cell receptors exhibit diverse therapeutic capability.
- Published in:
- International Journal of Cancer, 2013, v. 132, n. 6, p. 1360, doi. 10.1002/ijc.27792
- By:
- Publication type:
- Article
PD-1 expression on Melan-A-reactive T cells increases during progression to metastatic disease.
- Published in:
- International Journal of Cancer, 2012, v. 130, n. 10, p. 2327, doi. 10.1002/ijc.26272
- By:
- Publication type:
- Article
Allorestricted T lymphocytes with a high avidity T-cell receptor towards NY-ESO-1 have potent anti-tumor activity.
- Published in:
- International Journal of Cancer, 2009, v. 125, n. 3, p. 649, doi. 10.1002/ijc.24414
- By:
- Publication type:
- Article